Standards, Options and Recommendations (SOR) for clinical care of squamous cell carcinoma of the oropharynx

被引:0
|
作者
Renaud-Salis, JL
Blanc-Vincent, MP
Brugère, J
Demard, F
Faucher, A
Gory-Delabaere, G
Pinsolle, J
机构
[1] SOR, FNCLCC, Operat Stand, F-75654 Paris 13, France
[2] Inst Bergonie, Bordeaux, France
[3] Inst Curie, Paris, France
[4] Ctr Antoine Lacassagne, F-06054 Nice, France
[5] Hop Pellegrin, F-33076 Bordeaux, France
关键词
oropharynx cancer; guidelines; cancer; neoplasms; adult; surgery; chemotherapy; radiotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Context: The "Standards, Options and Recommendations" (SOR) project, started in 1993, is a collaboration between the Federation of the French Cancer Centres (FNCLCC), the 20, French Cancer Centres and specialists from French Public Universities, General Hospitals and Private Clinics. The main objective is the development of clinical practice guidelines to improve the quality of health care and outcome for cancer patients. The methodology is based on literature systematic review and critical appraisal by a multidisciplinary group of experts, with feedback from specialists in cancer care delivery. Objectives: To develop clinical practice guidelines according to the definitions of Standards, Options and Recommendations for the management of squamous carcinoma of the oropharynx. Methods: Data have been identified by literature search using Medline (1991-1998) and the expert groups personal reference lists. Once the guidelines were defined, the document was submitted for review to national and international independent reviewers and to the medical committees of the 20 French Cancer Centres. Results: The main recommendations for squamous cell carcinoma of the oropharynx management are that: 1) diagnosis and initial assessment should be based on appropriate clinical and radiological findings; 2) the therapeutic strategy is based on surgery, radiotherapy, bradytherapy and chemotherapy; 3) in limited tumours, the recommended strategy involved the use of one of these modality; 4) a multimodality approach is recommended for the treatment of extended resecable tumours. Following results of recent meta-analyses, use of neo-adjuvant chemotherapy is not recommended The same studies have shown that association of chemotherapy and radiotherapy either in sequence or in combination significantly improve survival of extended curable tumours. These associations are recommended within the framework of clinical trials; 5) follow-up of squamous carcinoma of the oropharynx should involve physical examination of the upper aerodigestive tract and the lymph nodes areas every three months during the first year, every six months during the second year and then every year An annual chest x-ray is recommended. Other investigations should be performed as indicated by symptoms and clinical manifestations.
引用
收藏
页码:550 / 572
页数:23
相关论文
共 50 条
  • [21] Clinical and molecular characterization of oropharynx squamous cell carcinoma samples.
    de Carvalho, Ana Carolina
    Sorroche, Bruna Pereira
    Melendez, Matias Eliseo
    Sabato, Cristina da Silva
    Palmero, Edenir Inez
    Rebolho Batista Arantes, Lidia Maria
    Scapulatempo Neto, Cristovam
    Carvalho, Andre Lopes
    CLINICAL CANCER RESEARCH, 2018, 24 (01) : 37 - 38
  • [22] Standards, Options and Recommendations (SOR) for diagnosis, treatment and follow-up of osteosarcoma
    Philip, T
    Blay, JY
    Brunat-Mentigny, M
    Carrie, C
    Chauvot, P
    Farsi, F
    Fervers, B
    Gentet, JC
    Giammarile, F
    Kohler, R
    Mathoulin, S
    Patricot, LM
    Thiesse, P
    BULLETIN DU CANCER, 1999, 86 (02) : 159 - 176
  • [23] Standards, Options and Recommendations (SOR):: clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma
    Négrier, S
    Fervers, B
    Bailly, C
    Beckendorf, V
    Cupissolv, D
    Doré, JF
    Dorval, T
    Garbay, JR
    Vilmer, C
    BULLETIN DU CANCER, 2000, 87 (02) : 173 - 182
  • [24] Margin Analysis Squamous Cell Carcinoma of the Oropharynx
    Sim, Felix W.
    Xiao, Hong D.
    Bell, R. Bryan
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2017, 29 (03) : 269 - +
  • [25] Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials
    Giunta, Emilio Francesco
    Bregni, Giacomo
    Hendlisz, Alain
    Sclafani, Francesco
    CURRENT OPINION IN ONCOLOGY, 2021, 33 (04) : 372 - 377
  • [26] CHEMOTHERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE OROPHARYNX
    ARNHOLDSCHNEIDER, M
    POLYZOIDIS, T
    HNO, 1987, 35 (11) : 468 - 471
  • [27] Wnt signaling in oropharynx squamous cell carcinoma
    Papagerakis, S
    Shabana, AH
    Depondt, J
    Berdal, A
    Thornhill, M
    ORAL ONCOLOGY, 2005, 1 (01) : 174 - 174
  • [28] Clinical and Molecular Characterization of Surgically Treated Oropharynx Squamous Cell Carcinoma Samples
    de Carvalho, Ana Carolina
    Melendez, Matias Eliseo
    Sabato, Cristina da Silva
    Palmero, Edenir Inez
    Rebolho Batista Arantes, Lidia Maria
    Neto, Cristovam Scapulatempo
    Carvalho, Andre Lopes
    PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (03) : 1047 - 1058
  • [29] Standards, Options and Recommendations (SOR) for good practices in dentistry for head and neck cancer patients
    Maire, F
    Borowski, B
    Collangettes, D
    Farsi, F
    Guichard, M
    Gourmet, R
    Kreher, P
    BULLETIN DU CANCER, 1999, 86 (7-8) : 640 - 665
  • [30] Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer
    Mauriac, L
    Blanc-Vincent, MP
    Luporsi, E
    Cutuli, B
    Fourquet, A
    Garbay, JR
    Giard, S
    Spyratos, F
    Zafrani, B
    Dilhuydy, JM
    BULLETIN DU CANCER, 2000, 87 (06) : 469 - 490